Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR
Diabetic patients using the triple-combination medication, Glimepiride/Metformin/Voglibose 2mg/500mg/0.2mg SR tablets (Genericart), should understand its purpose as an antidiabetic agent for managing type 2 diabetes in adults. This medication effectively regulates blood glucose levels. Administer this drug with food, consistently at the same time daily for optimal results. Dosage adjustments will be determined by your physician based on your blood sugar monitoring. Continued use is crucial; discontinuation without medical guidance may lead to dangerously elevated blood glucose, potentially causing kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan, which necessitates adherence to a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle modifications are paramount in controlling diabetes. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Knowing these symptoms and having readily available glucose sources (e.g., sugary foods or juice) is crucial. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are necessary under your physician's guidance.
Uses of Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Extended-Release Tablet should be taken on an empty stomach.
Common Side effects of Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg SR tablets should be taken on an empty stomach.
How Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR works:
Glimepiride, metformin, and voglibose (Genericart brand) are combined in a sustained-release tablet (2mg/500mg/0.2mg) to manage diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The combination medication Glimepiride+Metformin+Voglibose (Genericart) 2mg/500mg/0.2mg SR tablets may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg SR tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The combination medication Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR poses a likely risk for individuals with impaired kidney function and its use should be strictly avoided. Medical advice is essential. Furthermore, this medication is unsuitable for patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Glimepiride/Metformin/Voglibose 2mg/500mg/0.2mg tablets cautiously. Dosage modification may be necessary. Medical advice is recommended. A low initial dose is usually prescribed for those with mild to moderate liver disease; the medication is generally unsuitable for patients with severe hepatic dysfunction.
What if you forget to take Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR :
Should you forget a dose of Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Genericart Glimepiride+Metformin+Voglibose 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently